PLYMOUTH, Minn., May 15 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq:
EVVV) today announced that Pat Spangler, senior vice president and chief
financial officer, is scheduled to present at the 2008 FBR Capital Markets
Spring Investor Conference on Thursday, May 29, 2008 at 2:20 p.m. Eastern
Time (1:20 p.m. Central Time and 11:20 a.m. Pacific Time). The 2008 FBR
Capital Markets Spring Investor Conference will be held at the Grand Hyatt
Hotel, located at 109 East 42nd Street, New York, NY.
To access the webcast, go to the investors' section of the ev3 Web site
at http://www.ev3.net and click on the Webcast icon. The Webcast will be
available for replay approximately one hour after the presentation is
complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to improving the
lives of patients with vascular disease through the development of
innovative endovascular therapies. ev3's products are used by endovascular
specialists to treat a wide range of peripheral vascular and neurovascular
diseases and disorders. The company offers a comprehensive portfolio of
treatment options, including the primary interventional technologies used
today -- peripheral angioplasty balloons, stents, plaque excision systems,
embolic protection devices, liquid embolics, embolization coils,
thrombectomy catheters and occlusion balloons. More information about the
company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S.
and other countries.
See Also
- Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
- Making Chocolate Good For You: Why Raw Is Better
- Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
- EBI and Visibility Software Fuse Award Winning Solutions and Proven Technologies to Create Unique Talent Management and Screening Interface for HR Recruiters
Via: Healthcare
0 коментарі:
Post a Comment